The current HJLI market cap is 98.32M. The company's latest EPS is USD -2.4827 and P/E is -4.18.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -6.15M | -6.46M | -6.8M | -6.81M | -5.35M |
Net Income | -6.1M | -6.18M | -6.39M | -6.47M | -5M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 31k | 0 | 0 | 0 | 0 |
Operating Income | -7.09M | -9.14M | -16.89M | -24.93M | -25.24M |
Net Income | -7.63M | -9.74M | -16.53M | -24.67M | -23.52M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 45.46M | 41.66M | 36.61M | 32.09M | 28.09M |
Total Liabilities | 2.79M | 2.93M | 2.48M | 3.27M | 3.18M |
Total Equity | 42.67M | 38.73M | 34.13M | 28.81M | 24.92M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.43M | 10.54M | 57.7M | 41.66M | 48.64M |
Total Liabilities | 2.44M | 3.44M | 3.3M | 2.93M | 2.44M |
Total Equity | 990k | 7.1M | 54.4M | 38.73M | 46.2M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -11.76M | -15.62M | -5.11M | -9.67M | -13.89M |
Investing | -40.07M | -34.55M | 2.83M | 9.83M | 14.28M |
Financing | N/A | N/A | N/A | N/A | N/A |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -5.9M | -7.68M | -11.85M | -15.62M | -18.86M |
Investing | -364k | -180k | -368k | -34.55M | -7.87M |
Financing | 5.64M | 15.08M | 57.61M | N/A | 25.79M |
Market Cap | 98.32M |
Price to Earnings Ratio | -4.18 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 27.16 |
Price to Book Ratio | 2.13 |
Dividend Yield | - |
Shares Outstanding | 9.47M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.7 (6.54%) |
Company Name | Hancock Jaffe Laboratories Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.envveno.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.